Autocrine growth loops dependent on peptidyl α-amidating enzyme as targets for novel tumor cell growth inhibitors

Lung Cancer

Volumn 23, Issue 3, 1999, Pages 209-222

  Iwai, Naomichi ^a   Martínez, Alfredo ^a   Miller, Mae Jean ^a   Vos, Michele ^a   Mulshine, James L ^a   Treston, Anthony M ^a  

^a Division of Clinical Sciences   (United States)

Author keywords

Autocrine growth factors; Lung cancer; Peptide hormone; Post translational processing; Tumor growth inhibition

Indexed keywords

ALPHA AMIDATING ENZYME; GASTRIN RELEASING PEPTIDE; GROWTH FACTOR; HYGROMYCIN;

ARTICLE; BIOSYNTHESIS; CANCER INHIBITION; CELL PROLIFERATION; CLONOGENIC ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; TUMOR GROWTH;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTOCRINE COMMUNICATION; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CELL DIVISION; CINNAMATES; CULTURE MEDIA, CONDITIONED; DITIOCARB; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, MONOUNSATURATED; GROWTH INHIBITORS; HUMANS; HYGROMYCIN B; LUNG NEOPLASMS; MIXED FUNCTION OXYGENASES; MULTIENZYME COMPLEXES; OLIGONUCLEOTIDES, ANTISENSE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0344258315     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(99)00015-X     Document Type: Article

References (40)

1. Sporn M.B., Todaro G.J. Autocrine secretion and malignant transformation of cells. New Engl J Med. 303:1980;878-880.
2. Sporn M.B., Roberts A.B. Peptide growth factors are multifunctional. Nature. 332:1988;217-219.
3. Cuttitta F., Kasprzyk P.G., Treston A.M., Avis I., Jensen S., Levitt M., Sigfried J., Mobley C., Mulshine J.L. Autocrine growth factors which regulate the proliferation of pulmonary malignancies in man. Thomassen D., Nettesheim P. Autocrine growth factors which regulate the proliferation of pulmonary malignancies in man. 1989;228-270 Hemisphere Publishing Co, New York.
4. Quinn K.A., Treston A.M., Unsworth E.J., Miller M.-J., Vos M., Grimley C., Battey J., Mulshine J.L., Cuttitta F. Insulin-like growth factor expression in human cancer cell lines. J Biol Chem. 271:1996;11477-11483.
5. Vos M., Scott F.M., Iwai N., Treston A.M. Expression in human lung cancer cell lines of genes of prohormone processing and the neuroendocrine phenotype. J Cell Biochem Suppl. 24:1996;257-268.
6. Mulshine J.L., Natale R.B., Avis I., Treston A.M., Kasprzyk P.G., Nakanishi Y., Sausville E.A., Trepel J.B., Cuttitta F. Autocrine growth factors and lung cancer. Hansen H. Autocrine growth factors and lung cancer. 1989;107-122 Kluwer Academic Publishers, Boston, MA.
7. Mulshine J.L., Birrer M., Treston A.M., Scott F., Quinn K., Avis I., Cuttitta F. Growth factors and other targets for rational application as intervention agents. Newell G.R., Hong W.K. Growth factors and other targets for rational application as intervention agents. 1992;81-88 Plenum Press, New York.
8. Treston A.M., Mulshine J.L., Cuttitta F. Control of tumor cell biology through regulation of peptide hormone processing. J Natl Cancer Inst Monograph. 13:1992;169-175.
9. Cuttitta F., Carney D., Mulshine J., Moody T., Fedorko J., Fischler A., Minna J. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature. 316:1985;823-826.
10. Kelley M., Avis I., Linnoila R., Richardson G., Snider R., Phares J., Ashburn R., Laskin W., Becker K., Boland C., Cuttitta F., Mulshine J., Johnson B. Complete response in a patient with small cell lung cancer treated on a Phase II trial using a murine monoclonal antibody directed against gastrin releasing peptide. Am Soc Clin Oncol. 12:1993;339.
11. Mains R.E., Dickerson I.M., May V., Stoffers D.A., Perkins S.N., Ouafik L.H., Husten E.J., Eipper B.A. Cellular and molecular aspects of peptide hormone biosynthesis. Front Neuroendocrinol. 11:1990;52-89.
12. Merkler D.S. C-terminal amidated peptides: production by the in vitro enzymatic amidation of glycine-extended peptides and the importance of the amide to bioactivity. Enzyme Microb Technol. 16:1994;450-456.
13. Quinn K.A., Treston A.M., Scott F.M., Kasprzyk P.G., Avis I., Siegfried J. M., Mulshine J.L., Cuttitta F. Amidation of peptide hormones in lung cancer. Cancer Cells. 3:1992;504-510.
14. Treston A., Scott F., Vos M., lwai N., Mains R., Eipper B., Cuttitta F., Mulshine J. Biochemical characterization of peptide α-amidation enzyme activities of human neuroendocrine lung cancer cell lines. Cell Growth Diff. 4:1993;911-920.
15. Eipper B.A., Green C.B.-R., Mains R.E. Expression of prohormone processing enzymes in neuroendocrine and non-neuroendocrine cells. J Natl Cancer Inst Monogr. 13:1992;163-168.
16. Martínez A., Farr A., Vos M.D., Cuttitta F., Treston A.M. Peptide-amidating enzymes are expressed in the stellate epithelial cells of the thymic medulla. J Histochem Cytochem. 46:1998;661-668.
17. Saldise L., Martínez A., Montuenga L.M., Treston A., Springall D., Polak J.M., Vázquez J.J. Distribution of peptidyl-glycine α-amidating monooxygenase (PAM) enzymes in normal lung, and in lung epithelial tumors. J Histochem Cytochem. 44:1996;3-12.
18. Katopodis A.G., Ping D., May S.W. A novel enzyme from bovine neurointermediate pituitary catalyses dealkylation of α-hydroxyglycine derivatives, thereby functioning sequentially with peptidylglycine α-amidating, monooxygenase in peptide amidation. Biochemistry. 29:1990;6115-6120.
19. Eipper B.A., Stoffers D.S., Mains R.E. The biosynthesis of neuropeptides: peptide α-amidation. Annu Rev Neurosci. 15:1992;57-85.
20. Kato I., Yonekura H., Tajima M., Yanagi M., Yamamoto H., Okamoto H. Two enzymes concerned in peptide hormone α-amidation are synthesized from a single mRNA. Biochem Biophys Res Commun. 172:1990;197-203.
21. Perkins S.N., Husten E.J., Eipper B.A. The 108-kDa peptidylglycine α-amidating monooxygenase precursor contains two separable enzymatic activities involved in peptide amidation. Biochem Biophys Res Commun. 171:1991;926-932.
22. Takahashi K., Okamoto H., Seino H., Noguchi M. Peptidylglycine α-amidating reaction: evidence for a two-step mechanism involving a stable intermediate at neutral pH. Biochem Biophys Res Commun. 169:1990;524-530.
23. Bradbury A.F., Smyth D.G. Enzyme-catalysed peptide amidation: isolation of a stable intermediate formed by reaction of the amidating enzyme with an imino acid. Eur J Biochem. 169:1987;579-584.
24. Katopodis A.G., May S.W. Novel substrates and inhibitors of peptidyl-lycine α-amidating monooxygenase. Biochemistry. 29:1990;4541-4548.
25. Bradbury A.F., Mistry J., Roos B.A., Smyth D.G. 4-Phenyl-3-butenoic acid, an in vivo inhibitor of peptidylglycine hydroxylase (peptide amidating enzyme). Eur J Biochem. 189:1990;363-368.
26. Phelps R., Johnson B., Ihde D., Gazdar A., Carbone D., McClintock P., Linnoila R., Matthews M., Bunn P. Jr., Carney D., Minna J., Mulshine J. NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem Suppl. 24:1996;32-91.
27. Nakanishi Y., Mulshine J.L., Kasprzyk P.G., Natale R.B., Maneckjee R., Avis I., Treston A.M., Gazdar A.F., Minna J.D., Cuttitta F. Insulin-like growth factor-1 can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro, J Clin Invest. 82:1988;354-359.
28. Nakanishi Y., Cuttitta F., Kasprzyk P.G., Treston A.M., Avis I., Minna J.D., Kleinman H.K., Mulshine J.L. The effects of growth factors on the in vitro growth of small cell lung cancer as determined in a calorimetric assay. Rosen S., Mulshine J., Cuttitta F., Abrams P. The effects of growth factors on the in vitro growth of small cell lung cancer as determined in a calorimetric assay. 1988;59-89 Marcel Dekker, New York.
29. Glauder J., Ragg H., Rauch J., Engels J.W. Human peptidylglycine α-amidating monooxygenase: cDNA, cloning and functional expression of a truncated form in cos cells. Biochem Biophys Res Commun. 169:1990;551-558.
30. Hauer C., Getty R., Tykocinski M. Epstein-Barr virus episome-based promoter function in human myeloid cells. Nucleic Acids Res. 17:1989;1989-2003.
31. Wand G.S., Ney R.L., Baylin S., Eipper B., Mains R.E. Characterization of a peptide α-amidation activity in human plasma and tissues. Metabolism. 34:1985;1044-1052.
32. Mulshine J., Linnoila R., Jensen S., Magnani J., Tockman M., Gupta P.K., Scott F., Avis I., Quinn K., Birrer M., Treston A., Cuttitta F. Rational targets for the early detection of lung cancer. J Natl Cancer Inst Monogr. 13:1992;183-190.
33. Mulshine J.L., Treston A.M., Brown P.H., Birrer M.J., Shaw G.L. Initiators and promoters of lung cancer. Chest. 103:1993;4S-11S.
34. Martínez A., Treston A.M., Saldise L., Montuenga L.M., Linnoila R.I. Expression of peptidyl-glycine α-amidating monooxygenase (PAM) enzymes in morphological abnormalities adjacent to pulmonary tumors. Am J Pathol. 149:1996;707-716.
35. Mashiba H., Matsunaga K. Augmented inhibition of tumor cell proliferation in the combined use of disulfiram with ascorbic acid and the involvement of oxygen free radicals. Jpn J Exp Med. 60:1990;209-214.
36. Said S.I. Peptide hormones and neurotransmitters of the lung. Beeker K., Gazdar A. Peptide hormones and neurotransmitters of the lung. 1984;267-276 W.B. Saunders Co, Philadelphia, PA.
37. Neuenschwander S., Roberts C., LeRoith D. Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor 1 receptor antisense ribonucleic acid. Endocrinology. 136:1995;4298-4303.
38. Denhardt D. Mechanism of action of antisense RNA. Ann NY Acad Sci. 660:1992;70-76.
39. Crystal R. Transfer of genes to humans: early lessons and obstacles to success. Science. 270:1995;404-410.
40. Martínez A., Treston A. Where does amidation take place. Mol Cell Endocrinol. 123:1996;113-117.